Lapatinib lands leading role in trastuzumab-resistant breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1544, 2006-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Trastuzumab for Breast Cancer: The Role of Age

Current Pharmaceutical Design, Vol. 20, Iss. 38, 2014-11 ,pp. : 5957-5962

Bentham Science Publishers

Access to resources Recommend Favorite

Lapatinib: A Review of its Use in the Treatment of HER2-Overexpressing, Trastuzumab-Refractory, Advanced or Metastatic Breast Cancer

By Frampton James E.

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2125-2148

Adis International

Access to resources Recommend Favorite

Neoadjuvant trastuzumab promising in breast cancer

Inpharma, Vol. 1, Iss. 1484, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

In defence of trastuzumab for early breast cancer

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Trastuzumab: a revolutionary development in breast cancer

Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite